This is the authors' abstract. We don't add key points for this paper.
You have accessJournal of UrologyPediatrics II (MP21)1 May 2024MP21-17 EXPLORING TRENDS IN UTILIZATION AND COST OF NUCLEAR MEDICINE RENAL SCANS, RENAL ULTRASOUND, AND VOIDING CYSTOURETHROGRAPHY FOR CHILDREN WITH RENAL ANOMALIES USING A NATIONAL CLAIMS DATABASE Pranaya Venkatapuram and Daniel Han Pranaya VenkatapuramPranaya Venkatapuram and Daniel HanDaniel Han View All Author Informationhttps://doi.org/10.1097/01.JU.0001008844.84871.17.17AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Current 'gold standards' for imaging to obtain differential renal function in children with renal anomalies include nuclear medicine renal scans (i.e., MAG3 scan or DMSA scan). Renal ultrasounds (US) and voiding cystourethrography (VCUG) are also used in this population. Using a national claims database, we explored trends in total utilization and cost of MAG3 scans, DMSA scans, renal US, and VCUG from 2007-2021 among children with renal anomalies. METHODS: We retrospectively reviewed the Merative™ Marketscan® Commercial Database from 2007-2021 to identify a cohort of 0-18 year old patients diagnosed with renal anomalies (i.e., hydronephrosis, vesicoureteral reflux (VUR), posterior urethral valve (PUV), pyelonephritis, ureteropelvic junction/ureterovesical junction (UPJ/UVJ) obstruction, neurogenic bladder, and other specified disorders of the kidney and ureter) via diagnostic codes. We characterized total utilization and average cost per procedure of MAG3 scans, DMSA, scans, renal US, and VCUG by diagnosis in this cohort from 2007-2021. Statistical analyses were performed using R and Excel. RESULTS: We identified 1,769 unique patients with specific renal anomalies. The majority of patients were 0-5 years of age (63.14%) and female (54.95%) and had one of the following diagnoses: hydronephrosis (55.46%), VUR (32.96%), PUV (<5.0%), pyelonephritis (6.67%), UPJ obstruction (<5.0%), UVJ obstruction (<5.0%), neurogenic bladder (6.34%), or other specified disorders of kidney and ureter (19.11%). Less than 5% of patients received a DMSA scan, 7.87% received a MAG3 scan, 63.39% received a renal US, and 26.99% received a VCUG. Total utilization and average cost per procedure of from 2007-2021 varied by diagnosis (Table 1). Renal US was the most utilized imaging modality across all diagnoses. When compared to MAG3 and DMSA scans, the average cost of renal US was lower. CONCLUSIONS: We present a pediatric cohort with specific renal anomalies to explore total utilization and average cost per procedure of four diagnostic imaging modalities in a national claims database. This cohort allows us to perform future epidemiological analyses to understand trends in utilization and cost among children with renal anomalies. Source of Funding: None © 2024 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 211Issue 5SMay 2024Page: e336 Advertisement Copyright & Permissions© 2024 by American Urological Association Education and Research, Inc.Metrics Author Information Pranaya Venkatapuram More articles by this author Daniel Han More articles by this author Expand All Advertisement PDF downloadLoading ...
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Venkatapuram et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: